BriaCell Therapeutics Corp. (BCTX) Return on Assets (2022 - 2026)
BriaCell Therapeutics (BCTX) posted Return on Assets of 0.01% for Q2 2026, up 20.32% sequentially from 0.01% in Q1 2026, and up 1.0% YoY from 0.01% in Q2 2025.
BriaCell Therapeutics Corp. (BCTX) Return on Assets (2022 - 2026) Analysis & Trends
BriaCell Therapeutics has reported Return on Assets for 5 years, with the latest figure at 0.01% in Q2 2026.
- Quarterly Return on Assets rose 1.0% year-over-year to 0.01% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 0.01% (up 1.0% YoY) and the FY2025 annual result came in at 0.04%, down 1.0% from the prior year.
- Return on Assets climbed to 0.01% in Q2 2026 per BCTX's latest filing, from 0.01% in the prior quarter.
- Over five years, Return on Assets peaked at 0.0% in Q2 2022 and troughed at 0.05% in Q3 2024.
- A 5-year average of 0.02% and a median of 0.01% in 2026 frame the typical range for Return on Assets.
- The sharpest annual moves came in 2024 and 2025: Return on Assets decreased 5 bps in 2024, then grew 4 bps in 2025.
- Over 5 years, Return on Assets stood at 0.0% in 2022, then plunged by 174 bps to 0.01% in 2023, then slumped by 183 bps to 0.04% in 2024, then soared by 53 bps to 0.02% in 2025, then jumped by 40 bps to 0.01% in 2026.
- According to Business Quant data, Return on Assets over the past three periods registered 0.01%, 0.01%, and 0.02% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -0.01% |
| Jan 31, 2026 | -0.01% |
| Oct 31, 2025 | -0.02% |
| Jul 31, 2025 | -0.01% |
| Apr 30, 2025 | -0.02% |
| Jan 31, 2025 | -0.03% |
| Oct 31, 2024 | -0.04% |
| Jul 31, 2024 | -0.05% |
| Apr 30, 2024 | -0.04% |
| Jan 31, 2024 | -0.02% |
| Oct 31, 2023 | -0.01% |
| Jul 31, 2023 | -0.01% |
| Apr 30, 2023 | -0.01% |
| Jan 31, 2023 | -0.01% |
| Oct 31, 2022 | 0.00% |
| Jul 31, 2022 | 0.00% |
| Apr 30, 2022 | 0.00% |